Prevent cancer
Reduce risks:
e.g. Preventive vaccines
Ending virus-driven cancer
Best-in-class
virus-targeted immunotherapies, in oncology and beyond
Introduction
Pioneering immunotherapy to treat virus-driven disease
Globally, nearly 1.4 million new cancer cases are ascribed to viral infections, accounting for 8% of all cancer. Infections are the second leading preventable cause of cancer worldwide, after tobacco and ahead of alcohol.
With our team of specialists, we have developed Launch-iT, a novel platform to create virus-targeted immunotherapies that address some of today’s most urgent medical needs in oncology and beyond.
Virus-driven Cancer
A new therapeutic space
We develop immunotherapies to eliminate the virus before it causes cancer. Our approach opens a new therapeutic space alongside prevention and treatment, bringing hope to millions of people who know they are at risk of cancer but currently have no therapeutic option.
Healthy
Screening NEGATIVEInfection / Pre-cancer
Screening POSITIVEIntercept cancer
Virus: Targeted
Immunotherapy
Where Astrivax comes inCancer
Screening POSITIVETreat cancer
Imunnotherapy, e.g.
checkpoint inhibitors
See how we solve this problem?
TechnologyI am a heading
Ending HPV-driven cancer
Here goes your text … Select any part of your text to access the formatting toolbar.